Mirtazapin Sandoz (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonises postsynaptic 5‑HT2, 5‑HT3 and histamine H1 receptors, enhancing serotonergic activity while producing a calming, sedative effect that contributes to its antidepressant action.

The appropriate dose of Mirtazapin Sandoz is individualized by the prescribing clinician based on the patient’s clinical condition, response to therapy, age, liver function and any concomitant medications. The prescriber will decide the starting dose and any subsequent adjustments, following local prescribing guidelines.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Mirtazapin Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapin Sandoz belongs to the NaSSA class, which differs from selective serotonin reuptake inhibitors (SSRIs) by also blocking histamine H1 receptors, often causing sedation and weight gain. Compared with SSRIs, it may be preferred when patients need a sedating effect or have poor appetite, but individual response and side‑effect profiles guide the choice.

Store Mirtazapin Sandoz tablets at ambient temperature below 25 °C, in the original container, protected from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Mirtazapin Sandoz is taken orally, usually once daily in the evening because of its sedative properties. It may be swallowed with or without food, but patients should follow the specific instructions provided by their prescriber or pharmacist.

Serious risks include agranulocytosis or severe neutropenia, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, and the emergence or worsening of suicidal thoughts, especially during the early weeks of treatment. Patients should be monitored closely for any signs of infection, rash, or changes in mood.

Mirtazapin Sandoz is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients. Caution is advised for individuals taking monoamine oxidase inhibitors, those with severe hepatic impairment, or patients with a history of bipolar disorder who may experience a switch to mania if not co‑treated appropriately.